08:25 AM EDT, 08/15/2024 (MT Newswires) -- J Matthew Singleton, Director, on August 14, 2024, sold 20,786 shares in Viking Therapeutics ( VKTX ) for $1,195,736. Following the Form 4 filing with the SEC, Singleton has control over a total of 9,500 shares of the company, with 9,500 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1607678/000095017024097325/xslF345X03/ownership.xml

Price: 58.40, Change: +0.20, Percent Change: +0.34